Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day

OBJECTIVE: To evaluate the treatment effect size throughout the day of amphetamine extended-release oral suspension (AMPH EROS; Tris Pharma, Inc., Monmouth Junction, NJ, USA) in a laboratory classroom study conducted in children aged 6–12 years with attention-deficit/hyperactivity disorder (ADHD). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Faraone, Stephen V., Childress, Ann C., Gomeni, Roberto, Rafla, Eman, Kando, Judith C., Dansie, Lori, Naik, Payal, Pardo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963474/
https://www.ncbi.nlm.nih.gov/pubmed/36730749
http://dx.doi.org/10.1089/cap.2022.0093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963474/
https://www.ncbi.nlm.nih.gov/pubmed/36730749
http://dx.doi.org/10.1089/cap.2022.0093

Ejemplares similares